These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25900654)

  • 1. Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.
    Barbian HJ; Decker JM; Bibollet-Ruche F; Galimidi RP; West AP; Learn GH; Parrish NF; Iyer SS; Li Y; Pace CS; Song R; Huang Y; Denny TN; Mouquet H; Martin L; Acharya P; Zhang B; Kwong PD; Mascola JR; Verrips CT; Strokappe NM; Rutten L; McCoy LE; Weiss RA; Brown CS; Jackson R; Silvestri G; Connors M; Burton DR; Shaw GM; Nussenzweig MC; Bjorkman PJ; Ho DD; Farzan M; Hahn BH
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin and biology of simian immunodeficiency virus in wild-living western gorillas.
    Takehisa J; Kraus MH; Ayouba A; Bailes E; Van Heuverswyn F; Decker JM; Li Y; Rudicell RS; Learn GH; Neel C; Ngole EM; Shaw GM; Peeters M; Sharp PM; Hahn BH
    J Virol; 2009 Feb; 83(4):1635-48. PubMed ID: 19073717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir.
    Li Y; Ndjango JB; Learn GH; Ramirez MA; Keele BF; Bibollet-Ruche F; Liu W; Easlick JL; Decker JM; Rudicell RS; Inogwabini BI; Ahuka-Mundeke S; Leendertz FH; Reynolds V; Muller MN; Chancellor RL; Rundus AS; Simmons N; Worobey M; Shaw GM; Peeters M; Sharp PM; Hahn BH
    J Virol; 2012 Oct; 86(19):10776-91. PubMed ID: 22837215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.
    Bibollet-Ruche F; Russell RM; Ding W; Liu W; Li Y; Wagh K; Wrapp D; Habib R; Skelly AN; Roark RS; Sherrill-Mix S; Wang S; Rando J; Lindemuth E; Cruickshank K; Park Y; Baum R; Carey JW; Connell AJ; Li H; Giorgi EE; Song GS; Ding S; Finzi A; Newman A; Hernandez GE; Machiele E; Cain DW; Mansouri K; Lewis MG; Montefiori DC; Wiehe KJ; Alam SM; Teng IT; Kwong PD; Andrabi R; Verkoczy L; Burton DR; Korber BT; Saunders KO; Haynes BF; Edwards RJ; Shaw GM; Hahn BH
    mBio; 2023 Feb; 14(1):e0337022. PubMed ID: 36629414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon.
    Van Heuverswyn F; Li Y; Bailes E; Neel C; Lafay B; Keele BF; Shaw KS; Takehisa J; Kraus MH; Loul S; Butel C; Liegeois F; Yangda B; Sharp PM; Mpoudi-Ngole E; Delaporte E; Hahn BH; Peeters M
    Virology; 2007 Nov; 368(1):155-71. PubMed ID: 17651775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.
    Etienne L; Nerrienet E; LeBreton M; Bibila GT; Foupouapouognigni Y; Rousset D; Nana A; Djoko CF; Tamoufe U; Aghokeng AF; Mpoudi-Ngole E; Delaporte E; Peeters M; Wolfe ND; Ayouba A
    Retrovirology; 2011 Jan; 8():4. PubMed ID: 21232091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function.
    Kluge SF; Sauter D; Vogl M; Peeters M; Li Y; Bibollet-Ruche F; Hahn BH; Kirchhoff F
    Retrovirology; 2013 Mar; 10():32. PubMed ID: 23514615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii).
    Santiago ML; Lukasik M; Kamenya S; Li Y; Bibollet-Ruche F; Bailes E; Muller MN; Emery M; Goldenberg DA; Lwanga JS; Ayouba A; Nerrienet E; McClure HM; Heeney JL; Watts DP; Pusey AE; Collins DA; Wrangham RW; Goodall J; Brookfield JF; Sharp PM; Shaw GM; Hahn BH
    J Virol; 2003 Jul; 77(13):7545-62. PubMed ID: 12805455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of the HIV-1 group O epidemic in western lowland gorillas.
    D'arc M; Ayouba A; Esteban A; Learn GH; Boué V; Liegeois F; Etienne L; Tagg N; Leendertz FH; Boesch C; Madinda NF; Robbins MM; Gray M; Cournil A; Ooms M; Letko M; Simon VA; Sharp PM; Hahn BH; Delaporte E; Mpoudi Ngole E; Peeters M
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1343-52. PubMed ID: 25733890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of simian immunodeficiency virus infection in a large number of wild- and captive-born chimpanzees: evidence for a recent introduction following chimpanzee divergence.
    Switzer WM; Parekh B; Shanmugam V; Bhullar V; Phillips S; Ely JJ; Heneine W
    AIDS Res Hum Retroviruses; 2005 May; 21(5):335-42. PubMed ID: 15929695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
    Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.
    Morgand M; Bouvin-Pley M; Plantier JC; Moreau A; Alessandri E; Simon F; Pace CS; Pancera M; Ho DD; Poignard P; Bjorkman PJ; Mouquet H; Nussenzweig MC; Kwong PD; Baty D; Chames P; Braibant M; Barin F
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):237-45. PubMed ID: 26413851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee.
    Barbian HJ; Jackson-Jewett R; Brown CS; Bibollet-Ruche F; Learn GH; Decker T; Kreider EF; Li Y; Denny TN; Sharp PM; Shaw GM; Lifson J; Acosta EP; Saag MS; Bar KJ; Hahn BH
    Retrovirology; 2017 Jun; 14(1):35. PubMed ID: 28576126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas.
    Neel C; Etienne L; Li Y; Takehisa J; Rudicell RS; Bass IN; Moudindo J; Mebenga A; Esteban A; Van Heuverswyn F; Liegeois F; Kranzusch PJ; Walsh PD; Sanz CM; Morgan DB; Ndjango JB; Plantier JC; Locatelli S; Gonder MK; Leendertz FH; Boesch C; Todd A; Delaporte E; Mpoudi-Ngole E; Hahn BH; Peeters M
    J Virol; 2010 Feb; 84(3):1464-76. PubMed ID: 19906908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
    Twizerimana AP; Scheck R; Becker D; Zhang Z; Wammers M; Avelar L; Pflieger M; Häussinger D; Kurz T; Gohlke H; Münk C
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
    Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
    J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eCD4-Ig Limits HIV-1 Escape More Effectively than CD4-Ig or a Broadly Neutralizing Antibody.
    Fellinger CH; Gardner MR; Weber JA; Alfant B; Zhou AS; Farzan M
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.
    Gardner MR; Kattenhorn LM; Kondur HR; von Schaewen M; Dorfman T; Chiang JJ; Haworth KG; Decker JM; Alpert MD; Bailey CC; Neale ES; Fellinger CH; Joshi VR; Fuchs SP; Martinez-Navio JM; Quinlan BD; Yao AY; Mouquet H; Gorman J; Zhang B; Poignard P; Nussenzweig MC; Burton DR; Kwong PD; Piatak M; Lifson JD; Gao G; Desrosiers RC; Evans DT; Hahn BH; Ploss A; Cannon PM; Seaman MS; Farzan M
    Nature; 2015 Mar; 519(7541):87-91. PubMed ID: 25707797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses.
    Berendam SJ; Styles TM; Morgan-Asiedu PK; Tenney D; Kumar A; Obregon-Perko V; Bar KJ; Saunders KO; Santra S; De Paris K; Tomaras GD; Chahroudi A; Permar SR; Amara RR; Fouda GG
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.